Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?

Orphanet Journal of Rare Diseases

Volumn 7, Issue 1, 2012, Pages

  Bouvresse, Sophie ^a   Valeyrie Allanore, Laurence ^a   Ortonne, Nicolas ^a   Konstantinou, Marie Pauline ^a   Kardaun, Sylvia H ^b   Bagot, Martine ^c   Wolkenstein, Pierre ^a   Roujeau, Jean Claude ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c SAINT LOUIS HOSPITAL   (France)

Author keywords

AGEP; DRESS; Overlap; Severe cutaneous adverse reactions; Toxic epidermal necrolysis

Indexed keywords

ACUTE DISEASE; ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ARTICLE; DATA ANALYSIS; DRESS SYNDROME; DRUG ERUPTION; FRANCE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PATIENT REFERRAL; PREVALENCE; SKIN BIOPSY; STEVENS JOHNSON SYNDROME; SYNDROME DELINEATION; TOXIC EPIDERMAL NECROLYSIS;

EPIDERMAL NECROLYSIS, TOXIC; HUMANS; RETROSPECTIVE STUDIES;

EID: 84866542637     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-7-72     Document Type: Article

References (34)

1. Life-threatening acute adverse cutaneous drug reactions. Wolf R, Orion E, Marcos B, Matz H, Clin Dermatol 2005 23 2 171 181 15802211
2. Severe adverse cutaneous reactions to drugs. Roujeau JC, Stern RS, N Engl J Med 1994 331 19 1272 1285 10.1056/NEJM199411103311906 7794310
3. Drug-induced skin, nail and hair disorders. Valeyrie-Allanore L, Sassolas B, Roujeau JC, Drug Saf 2007 30 11 1011 1030 10.2165/00002018-200730110-00003 17973540
4. Acute generalized exanthematous pustulosis (AGEP)-a clinical reaction pattern. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC, J Cutan Pathol 2001 28 3 113 119 10.1034/j.1600-0560.2001.028003113.x 11168761
5. Risk factors for acute generalized exanthematous pustulosis (AGEP) - results of a multinational case-control study (EuroSCAR). Sidoroff A, Dunant A, Viboud C, et al. Br J Dermatol 2007 157 5 989 996 10.1111/j.1365-2133.2007. 08156.x 17854366
6. Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Bocquet H, Bagot M, Roujeau JC, Semin Cutan Med Surg 1996 15 4 250 257 10.1016/S1085-5629(96)80038-1 9069593
7. The DRESS syndrome: a literature review. Cacoub P, Musette P, Descamps V, et al. Am J Med 2011 124 7 588 597 10.1016/j.amjmed.2011.01.017 21592453
8. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, Roujeau JC, Br J Dermatol 2007 156 3 609 611 10.1111/j.1365-2133.2006.07704.x 17300272
9. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schröder W, Roujeau JC, SCAR Study Group. Severe Cutaneous Adverse Reactions, Arch Dermatol 2002 138 8 1019 1024 10.1001/archderm.138.8. 1019 12164739
10. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, Sidoroff A, Schneck J, Roujeau JC, Flahault A, J Invest Dermatol 2008 128 1 35 44 10.1038/sj.jid.5701033 17805350
11. Stevens-Johnson syndrome and toxic epidermal necrolysis induced by amifostine during head and neck radiotherapy. Valeyrie-Allanore L, Poulalhon N, Fagot JP, Sekula P, Davidovici B, Sidoroff A, Mockenhaupt M, Radiother Oncol 2008 87 2 300 303 10.1016/j.radonc.2008.01.021 18328585
12. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Roujeau JC, Bioulac-Sage P, Bourseau C, Guillaume JC, Bernard P, Lok C, Plantin P, Claudy A, Delavierre C, Vaillant L, Wechsler J, Danan G, Bénichou C, Beylot C, Arch Dermatol 1991 127 9 1333 1338 10.1001/archderm.1991. 01680080069004 1832534
13. Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts. Speeckaert MM, Speeckaert R, Lambert J, Brochez L, Eur J Dermatol 2010 20 4 425 433 20542841
14. Acute generalized exanthematous pustulosis simulating toxic epidermal necrolysis: a case report and review of the literature. Peermohamed S, Haber RM, Arch Dermatol 2011 147 6 697 701 10.1001/archdermatol.2011.147 21690532
15. Acute generalized exanthematic pustulosis. Machet ML, Vaillant L, Ann Dermatol Venereol 2001 128 1 73 79 11226910
16. Generalized pustulation as a manifestation of the anticonvulsant hypersensitivity syndrome. Kleier RS, Breneman DL, Boiko S, Arch Dermatol 1991 127 9 1361 1364 10.1001/archderm.1991.01680080097009 1832535
17. Drug hypersensitivity syndrome: DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). Begon E, Roujeau JC, Ann Dermatol Venereol 2004 131 3 293 297 10.1016/S0151-9638(04)93600-9 15107755
18. Drug Rash with eosinophilia and systemic symptoms versus Stevens-Johnson Syndrome-a case that indicates a stumbling block in the current classification. Wolf R, Davidovici B, Matz H, Mahlab K, Orion E, Sthoeger ZM, Int Arch Allergy Immunol 2006 141 3 308 310 10.1159/000095437 16940741
19. Hematologic anomalies in Lyells syndrome. Study of 26 cases. Bombal C, Roujeau JC, Kuentz M, Revuz J, Touraine R, Ann Dermatol Venereol 1983 110 2 113 119 6881853
20. Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Lebargy F, Wolkenstein P, Gisselbrecht M, Lange F, Fleury-Feith J, Delclaux C, Roupie E, Revuz J, Roujeau JC, Intensive Care Med 1997 23 12 1237 1244 10.1007/s001340050492 9470079
21. Renal involvement in toxic epidermal necrolysis. Blum L, Chosidow O, Rostoker G, Philippon C, Revuz J, Roujeau JC, J Am Acad Dermatol 1996 34 6 1088 1090 10.1016/S0190-9622(96)90297-2 8647982
22. Denominations and classification of severe cutaneous adverse reactions to drugs: splitters versus mergers. Valeyrie-Allanore L, Roujeau JC, Eur J Dermatol 2007 17 5 359 360 17673376
23. Auto-immune thyroiditis and drug reaction with eosinophilia and systemic symptoms (DRESS) associated with HHV-6 viral reactivation. Funck-Brentano E, Duong T, Family D, Bouaziz JD, Ortonne N, Bagot M, Roujeau JC, Wolkenstein P, Valeyrie-Allanore L, Ann Dermatol Venereol 2011 138 8-9 580 585 21893231
24. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Geudry J, Roujeau JC, Binaghi M, Soubrane G, Muraine M, Arch Dermatol 2009 145 2 157 162 10.1001/archdermatol.2009.540 19221260
25. Immune pathomechanism of drug hypersensitivity reactions. Pichler WJ, Naisbitt DJ, Park BK, J Allergy Clin Immunol 2011 127 3 74 S81 10.1016/j.jaci.2010.11.048 21354503
26. Drug hypersensitivity reactions: pathomechanism and clinical symptoms. Pichler WJ, Adam J, Daubner B, Gentinetta T, Keller M, Yerly D, Med Clin North Am 2010 94 4 645 664 10.1016/j.mcna.2010.04.003 20609855
27. Genetic predisposition of life-threatening antiepileptic-induced skin reactions. Chung WH, Hung SI, Chen YT, Expert Opin Drug Saf 2010 9 1 15 21 10.1517/14740330903427969 20001755
28. Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response. Picard D, Janela B, Descamps V, DIncan M, Courville P, Jacquot S, Rogez S, Mardivirin L, Moins-Teisserenc H, Toubert A, Benichou J, Joly P, Musette P, Sci Transl Med 2010 2 46 46ra62 10.1126/scitranslmed.3001116 20739682
29. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions. Yawalkar N, Shrikhande M, Hari Y, Nievergelt H, Braathen LR, Pichler WJ, J Allergy Clin Immunol 2000 106 6 1171 1176 10.1067/mai.2000.110922 11112902
30. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. Britschgi M, Steiner UC, Schmid S, Depta JP, Senti G, Bircher A, Burkhart C, Yawalkar N, Pichler WJ, J Clin Invest 2001 107 11 1433 1441 10.1172/JCI12118 11390425
31. Increased circulating Th17 frequencies and serum IL-22 levels in patients with acute generalized exanthematous pustulosis. Sugita K, Kabashima K, Sawada Y, Haruyama S, Yoshioka M, Mori T, Kobayashi M, Ogasawara K, Tokura Y, J Eur Acad Dermatol Venereol 2011 25 4 485 488 10.1111/j.1468-3083.2010.03771.x 20569282
32. Delayed drug hypersensitivity reactions. Pichler WJ, Ann Intern Med 2003 139 8 683 693 14568857
33. Clinical heterogeneity of drug hypersensitivity. Roujeau JC, Toxicology 2005 209 2 123 129 10.1016/j.tox.2004.12.022 15767024
34. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Hung SI, Chung WH, Jee SH, Chen WC, Chang YT, Lee WR, Hu SL, Wu MT, Chen GS, Wong TW, Hsiao PF, Chen WH, Shih HY, Fang WH, Wei CY, Lou YH, Huang YL, Lin JJ, Chen YT, Pharmacogenet Genomics 2006 16 4 297 306 10.1097/01.fpc. 0000199500.46842.4a 16538176